Literature DB >> 14724616

Tumour suppression: putting on the brakes.

Henry Harris1.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 14724616     DOI： 10.1038/427201a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

Review 1.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.

Authors:  Laura N Vandenberg; Theo Colborn; Tyrone B Hayes; Jerrold J Heindel; David R Jacobs; Duk-Hee Lee; Toshi Shioda; Ana M Soto; Frederick S vom Saal; Wade V Welshons; R Thomas Zoeller; John Peterson Myers
Journal:  Endocr Rev       Date:  2012-03-14       Impact factor: 19.871

Review 2.  p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies.

Authors:  Yogen Saunthararajah; Pierre Triozzi; Brian Rini; Arun Singh; Tomas Radivoyevitch; Mikkael Sekeres; Anjali Advani; Ramon Tiu; Frederic Reu; Matt Kalaycio; Ed Copelan; Eric Hsi; Alan Lichtin; Brian Bolwell
Journal:  Semin Oncol       Date:  2012-02       Impact factor: 4.929

3.  Induction of differentiation in the shoot apical meristem by transient overexpression of a retinoblastoma-related protein.

Authors:  Joanna Wyrzykowska; Martine Schorderet; Stéphane Pien; Wilhelm Gruissem; Andrew J Fleming
Journal:  Plant Physiol       Date:  2006-06-30       Impact factor: 8.340

Review 4.  Theories of carcinogenesis: an emerging perspective.

Authors:  Carlos Sonnenschein; Ana M Soto
Journal:  Semin Cancer Biol       Date:  2008-03-26       Impact factor: 15.707

Review 5.  The retinoblastoma tumor-suppressor gene, the exception that proves the rule.

Authors:  D W Goodrich
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

Review 6.  The role of cell differentiation in controlling cell multiplication and cancer.

Authors:  Karl-Hartmut von Wangenheim; Hans-Peter Peterson
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-15       Impact factor: 4.553

7.  Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens.

Authors:  Alice C Fan; Debabrita Deb-Basu; Mathias W Orban; Jason R Gotlib; Yasodha Natkunam; Roger O'Neill; Rose-Ann Padua; Liwen Xu; Daryl Taketa; Amy E Shirer; Shelly Beer; Ada X Yee; David W Voehringer; Dean W Felsher
Journal:  Nat Med       Date:  2009-04-12       Impact factor: 53.440

8.  The aging of the 2000 and 2011 Hallmarks of Cancer reviews: a critique.

Authors:  Carlos Sonnenschein; Ana M Soto
Journal:  J Biosci       Date:  2013-09       Impact factor: 1.826

9.  Astrocytes reverted to a neural progenitor-like state with transforming growth factor alpha are sensitized to cancerous transformation.

Authors:  Christelle Dufour; Josette Cadusseau; Pascale Varlet; Anne-Laure Surena; Giselle P de Faria; Amelie Dias-Morais; Nathalie Auger; Nadine Léonard; Estelle Daudigeos; Carmela Dantas-Barbosa; Jacques Grill; Vladimir Lazar; Philippe Dessen; Gilles Vassal; Vincent Prevot; Ariane Sharif; Herve Chneiweiss; Marie-Pierre Junier
Journal:  Stem Cells       Date:  2009-10       Impact factor: 6.277

10.  The atonal proneural transcription factor links differentiation and tumor formation in Drosophila.

Authors:  Wouter Bossuyt; Natalie De Geest; Stein Aerts; Iris Leenaerts; Peter Marynen; Bassem A Hassan
Journal:  PLoS Biol       Date:  2009-02-24       Impact factor: 8.029
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.